Ph. Eur. 2.1.7 revised: applicable from 1 January 2027
The European Pharmacopoeia chapter on balances for analytical purposes is among the revised texts of Issue 13.1 and applies from 1 January 2027. What is certain, what is known of the changes, and minimum weight.
Issue 13.1, applicable from 1 January 2027
Chapter 2.1.7 of the European Pharmacopoeia, "Balances for analytical purposes", has been revised. The new text is part of Ph. Eur. Issue 13.1, which the EDQM made available on 1 April 2026 and which applies in 39 European countries from 1 January 2027.
1 April 2026
Issue 13.1 available
1 January 2027
Revised texts come into force
39 countries
European countries where it applies
What is certain
Revised text
In the contents list of Issue 13.1, chapter 2.1.7 appears among the revised texts, that is, among those whose technical content has been revised since their last publication.
Entry into force
Revised texts come into force on 1 January 2027 and must be implemented by that date at the latest.
Current text
The chapter was adopted by the European Pharmacopoeia Commission in November 2020, published in Supplement 10.6 and applicable from 1 January 2022. The current text remains in force until 31 December 2026.
Final text
According to ECA Academy, the updated text can be viewed on the Pharmeuropa website after a one-time registration.
What changes
According to ECA Academy, the updated text can be viewed on the Pharmeuropa website after a one-time registration; the draft had been published in Pharmeuropa 37.1. The information below comes from a secondary source and should be checked against the official text.
The draft revision was published for public consultation in Pharmeuropa 37.1, with comments until 31 March 2025. According to the summary by ECA Academy, the draft defined two types of balance, the multi-interval balance (one weighing range divided into partial ranges with different scale intervals d) and the multiple range balance (several weighing ranges, each with its own scale interval d); expanded the section on minimum weight; updated the terms related to equipment performance; and added that calibrations and performance checks must be carried out under conditions that represent the routine operating conditions of the balance. On the final text, the same source reports a minimum weight section presented in much greater detail, the introduction of multi-interval and multiple range balances with different requirements, clarifications on equipment performance and formal changes.
Laboratories that weigh for the quality control of medicines have until the end of 2026 to compare their procedures with the revised text.
Minimum weight
Minimum weight is the smallest quantity of sample that can be weighed with the accuracy required by the process. Below that value, the measurement uncertainty takes too large a share of the result. It is not a fixed property of the model: it depends on the performance of the individual balance, starting with repeatability, under the conditions in which it is installed.
The EURAMET cg-18 guide derives it from the global uncertainty, that is, the uncertainty to be attributed to a weighing under conditions of use, calculated from the calibration results. The calculation depends on two values chosen by the user:
The accuracy required
By the process, expressed as the maximum acceptable relative uncertainty, for example 1 % or 0.1 %.
The safety factor SF
A number equal to or greater than 1 that accounts for conditions of use worse than those of the calibration.
Minimum weight according to the EURAMET cg-18 guide
On a laboratory balance with 60 g capacity and 0.01 mg readability, the example in an application note on minimum weight (link in the sources) gives these values:
| Accuracy required | SF = 1 | SF = 2 | SF = 3 |
|---|---|---|---|
| 0.1 % | 87.3 mg | 175.1 mg | 263.4 mg |
| 0.5 % | 17.4 mg | 34.8 mg | 52.3 mg |
| 1 % | 8.7 mg | 17.4 mg | 26.1 mg |
Between the most tolerant and the most demanding combination, the value grows about thirty times, on the same balance.
Room conditions
The safety factor exists because conditions of use are not those of the calibration. A 2025 study on analytical balances (Z. Mao, International Journal of Chemistry and Materials Science 2(1)) measured statistically significant errors with air currents of 0.2 m/s or more, up to ±0.4 mg, and with electrostatic charges of 1 kV or more. On a 10 mg sample, 0.4 mg is 4 %.
0.2 m/s
Air currents from which errors become significant
±0.4 mg
Largest error measured with air currents
1 kV
Electrostatic charges from which errors become significant
4 %
0.4 mg on a 10 mg sample
- EDQM, European Pharmacopoeia Issue 13.1 now available, 1 April 2026.
- Contents of Issue 13.1, copy published by the Norwegian Medical Products Agency (PDF).
- EDQM, Weighing according to the European Pharmacopoeia, 26 February 2022.
- ECA Academy, the draft of chapter 2.1.7 in Pharmeuropa 37.1, 8 January 2025, and the updated text now available, 15 April 2026.
- Z. Mao, A Study on the Effects of Airflow and Static Electricity on Analytical Balance Weighing, 2025.
- Application note on minimum weight according to EURAMET cg-18 (PDF): the full example, the safety factor and the criteria for choosing the accuracy.
- Global uncertainty and minimum weight in the certificate: the table and the chart of the safe weighing range.
- Ph. Eur. 2.1.7: the news item already published on the chapter in its 2022 version.
Gibertini Elettronica reports minimum weight according to the EURAMET cg-18 guide, on request, in the calibration certificate of LAT calibration center No. 00121.
Last updated: November 17, 2026